 |
 |
|
|
|
| Bortezomib |
 |
| Bortezomib |
 |
| 179324-69-7 |
 |
Antineoplastics.
|
 |
Appearance: White or off-white crystalline powder
Identification: (by NMR) The Nuclear Magnetic Resonance spectrum of the sample should be the same as that of reference material
Loss on drying: ≤0.5%
Burned ash: ≤0.1%
Heavy Metals: ≤20ppm
Assay(HPLC): ≥98.5% |
|
|
|
|
|
